Oct. 24 at 8:06 PM
$REGN
https://finance.yahoo.com/news/long-leaf-partners-fund-regeneron-171424649.html
Longleaf Partners Fund stated the following regarding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in its third quarter 2025 investor letter:
"After a slow start to our holding period this year, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has found its footing and grown its value per share back to above where we started the year in our opinion. We still do not have to pay anything for multiple high quality pipeline candidates, and the company has become one of our larger share repurchasers with its net cash balance sheet."